PERSPECTA

News from every angle

← Back to headlines

Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for aprevo lumbar

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

seeking-alphaglg2h ago

Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for aprevo lumbar

Read full article →

Related Stories

WHO tracing passengers on passenger flight with hantavirus infected Dutch woman

8m ago

WHO Traces Passengers After Hantavirus Case on Flight

8m ago

Health Risks Associated with Sitting Cross-Legged

8m ago

Novo Nordisk Reports Strong Q1 Sales, Raises Full-Year Expectations

11m ago